Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
Here, the authors show that sequential treatment with long-acting slow-effective release ART and AAV9- based delivery of CRISPR-Cas9 results in undetectable levels of virus and integrated DNA in a subset of humanized HIV-1 infected mice. This proof-of-concept study suggests that HIV-1 elimination is...
Guardado en:
Autores principales: | Prasanta K. Dash, Rafal Kaminski, Ramona Bella, Hang Su, Saumi Mathews, Taha M. Ahooyi, Chen Chen, Pietro Mancuso, Rahsan Sariyer, Pasquale Ferrante, Martina Donadoni, Jake A. Robinson, Brady Sillman, Zhiyi Lin, James R. Hilaire, Mary Banoub, Monalisha Elango, Nagsen Gautam, R. Lee Mosley, Larisa Y. Poluektova, JoEllyn McMillan, Aditya N. Bade, Santhi Gorantla, Ilker K. Sariyer, Tricia H. Burdo, Won-Bin Young, Shohreh Amini, Jennifer Gordon, Jeffrey M. Jacobson, Benson Edagwa, Kamel Khalili, Howard E. Gendelman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad4b010214414d8c84777d8ae90f684b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Creation of a long-acting nanoformulated dolutegravir
por: Brady Sillman, et al.
Publicado: (2018) -
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Nagsen Gautam, et al.
Publicado: (2021) -
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Denise A. Cobb, et al.
Publicado: (2021) -
CRISPR based editing of SIV proviral DNA in ART treated non-human primates
por: Pietro Mancuso, et al.
Publicado: (2020) -
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim IM, et al.
Publicado: (2019)